Analyst Coverage
| Firm | Analyst |
|---|---|
|
Baird
|
Brian Skorney
|
|
BMO Capital Markets
|
Do Kim
|
|
Citi Research
|
Mohit Bansal
|
|
Cowen & Co.
|
Phil Nadeau, Ph.D.
|
|
Credit Suisse
|
Evan Seigerman
|
|
Evercore ISI
|
Josh Schimmer
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim Securities
|
Whitney Ijem
|
|
HC Wainwright
|
Andrew Fein
|
|
Jefferies
|
Michael Yee
|
|
JMP Securities
|
Liisa Bayko
|
|
J.P. Morgan
|
Cory W. Kasimov
|
|
Leerink
|
Geoff Porges, Ph.D.
|
|
Maxim Group
|
Jason McCarthy
|
|
Morgan Stanley
|
Matthew Harrison
|
|
Needham & Company
|
Alan Carr, Ph.D.
|
|
Oppenheimer
|
Hartaj Singh
|
|
Piper Jaffray
|
Edward Tenthoff
|
|
RBC
|
Brian Abrahams, M.D.
|
|
Stifel
|
Paul Matteis
|
|
UBS Equities
|
Navin Jacob
|
Vertex Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.